Uni-Bio Science Group Limited (0690.HK) — Stock Score Summary

Uni-Bio Science Group Limited (0690.HK) has a MoatMap StockRank of 87/100 based on Quality (74/100), Value (72/100), and Momentum (28/100) factor scores. The current signal is STRONG BUY. A micro-cap Chinese biopharmaceutical company with highly speculative pipeline assets and no established commercial moat.

Uni-Bio Science Group Limited is a fully integrated biopharmaceutical company focused on the research, development, manufacture, and commercialization of novel therapeutics for endocrine, ophthalmic, and dermatological diseases. The company's proprietary products, such as GeneTime and GeneSoft, hold strong market positions in China's clinical sectors. It operates as an R&D-driven biotech player with established manufacturing facilities and a nationwide sales network.

Key Financial Metrics

Price$0.01
Market Cap$68M
P/E (TTM)4.25
Price/Book1.23
Return on Equity25.3%
Return on Invested Capital21.6%
Debt/Equity24.92
Gross Margin83.2%
Operating Margin6.5%
Revenue Growth-1.2%
Dividend Yield3.5%
Free Cash Flow$322K

Uni-Bio Science Group Limited operates in the Biotechnology industry, part of the Healthcare sector (Hong Kong).

Frequently Asked Questions

What is Uni-Bio Science Group Limited’s (0690.HK) StockRank?
MoatMap’s StockRank for Uni-Bio Science Group Limited (0690.HK) is 87/100, with a Strong Buy signal. It is a composite of Quality (74), Value (72), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does Uni-Bio Science Group Limited have an economic moat?
Uni-Bio Science Group Limited (0690.HK) has a Quality factor score of 74/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Uni-Bio Science Group Limited a buy, hold, or sell?
MoatMap’s current signal for Uni-Bio Science Group Limited (0690.HK) is Strong Buy, based on a StockRank of 87/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Uni-Bio Science Group Limited in?
Uni-Bio Science Group Limited (0690.HK) operates in the Healthcare sector, specifically the Biotechnology industry (Hong Kong).
Browse all ranked stocks0690.HK deep dive reportAI ChampionsHow we score stocksSense-check another stock